About Us
PulmoBioTech is a publically listed company which trades on the NASDAQ OTC (symbol PLMO).

The Board of Directors of PulmoBioTech Inc comprises:

Garry McCann, Director & CEO

Garry, age 49, is also the Managing Director of MC&C td, a UK business consulting company. Prior to these positions he was the Managing Director of NE Technology Ltd, a global leader in the design and manufacture of radiation detection equipment. Garry has also been active in the fields of CAT X-ray generators, medical imaging CCDs and IR Image Sensors. Garry has an MBA from Warwick University Business School and a BSc in Physics from the University of Surrey.

Ian Isley, Director

Ian, age 58, since 1984 has been the Managing Director of Bureau d'Administration de Services et d'Etudes (Monaco), a small but long-established Monegasque financial services and management consulting business that offers trust, offshore management and tax planning and related activities. Mr. Ilsley holds a degree in accountancy and business studies from Thames Valley University and is qualified as a Chartered Certified Accountant.

Rajiv Garg, Chief Financial Officer

Rajiv has twenty one years of extensive experience in the investment banking and finance industry covering financial control, evaluation of businesses, regulatory liaison and development of macro/micro risk management systems.

Rajiv was educated at Westminster College in London , UK and the University of Delhi in India . He has an Honours Degree in Commerce and is a Member of the Institute of Chartered Accountants , a Member of the Securities and Futures Authority and a Member of the Global Association of Risk Professionals.

Peter Hirshfield, Company Secretary

Peter has over 35 years of experience as outside general counsel specializing in corporate, business and securities law. In September 2004 he founded Hirshfield Law, a New York City law firm that represents emerging companies and entrepreneurs in all stages of their business life, from formation and routine business matters, through regulatory compliance, capital raising, restructuring, joint ventures, and merger and acquisition transactions. Peter has represented participants in reverse merger transactions and currently represents several public companies and a number of private companies. Prior to founding Hirshfield Law, Peter gained broad experience as a partner in several prominent New York City law firms and as an associate at Cravath, Swaine & Moore. He received his BA majoring in history from Brandeis University, Waltham MA, and his JD degree from New York University Law School, where he was Article & Book Review Editor of the NYU Law Review and a John Norton Pomeroy Scholar. Peter was admitted to the California Bar, where he is currently on inactive status, and is an active member of the New York Bar.


2008 Pulmo Biotech All rights reserved

web design by Lapbaby Designs
PulmoScience Montreal Heart Institute (MHI)